Cancer death is related to high palmitoleic acid in serum and to polymorphisms in the SCD-1 gene in healthy Swedish men

American Journal of Clinical Nutrition

Volumn 99, Issue 3, 2014, Pages 551-558

  Byberg, Liisa ^a   Kilander, Lena ^a   Lemming, Eva Warensjö ^a,b   Michaëlsson, Karl ^a   Vessby, Bengt ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b National Food Agency   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; CHOLESTEROL ESTER; PALMITIC ACID; PALMITOLEIC ACID;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CONTROLLED STUDY; ENZYME ACTIVITY; FAT INTAKE; FATTY ACID BLOOD LEVEL; FOLLOW UP; GAS LIQUID CHROMATOGRAPHY; GENETIC RISK; GENETIC VARIABILITY; HUMAN; HUMAN EXPERIMENT; LIPID COMPOSITION; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SURVIVAL; SWEDEN; VERY ELDERLY;

ADOLESCENT; ADULT; AGING; CHILD; CHOLESTEROL ESTERS; COHORT STUDIES; DIETARY FATS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; FOOD HABITS; GENETIC ASSOCIATION STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; STEAROYL-COA DESATURASE; SURVIVAL ANALYSIS; SWEDEN; YOUNG ADULT;

EID: 84896861481     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.065714     Document Type: Article

References (38)

1. Chajès V, Joulin V, Clavel-Chapelon F. The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk. Curr Opin Lipidol 2011;22:6-10.
2. Chajès V, Jenab M, Romieu I, Ferrari P, Dahm CC, Overvad K, Egeberg R, Tjonneland A, Clavel-Chapelon F, Boutron-Ruault MC, et al. Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Am J Clin Nutr 2011;94:1304-13.
3. Kuriki K, Wakai K, Matsuo K, Hiraki A, Suzuki T, Yamamura Y, Yamao K, Nakamura T, Tatematsu M, Tajima K. Gastric cancer risk and erythrocyte composition of docosahexaenoic acid with anti-inflammatory effects. Cancer Epidemiol Biomarkers Prev 2007;16:2406-15. (Pubitemid 351196374)
4. Macášek J, Vecka M, Zák A, Urbánek M, Krechler T, Petruzelka L, Stankova B, Zeman M. Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. Nutr Cancer 2012;64:946-55.
5. Chaudry A, McClinton S, Moffat LE, Wahle KW. Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease. Br J Cancer 1991;64:1157-60.
6. Crowe FL, Allen NE, Appleby PN, Overvad K, Aardestrup IV, Johnsen NF, Tjonneland A, Linseisen J, Kaaks R, Boeing H, et al. Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2008;88:1353-63.
7. Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, Vatten L. Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer 1997;71:545-51. (Pubitemid 27239362)
8. Männistö S, Pietinen P, Virtanen MJ, Salminen I, Albanes D, Giovannucci E, Virtamo J. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers. Cancer Epidemiol Biomarkers Prev 2003;12:1422-8. (Pubitemid 38031744)
9. Park SY, Wilkens LR, Henning SM, Le Marchand L, Gao K, Goodman MT, Murphy SP, Henderson BE, Kolonel LN. Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort. Cancer Causes Control 2009;20:211-23.
10. Zureik M, Ducimetière P, Warnet JM, Orssaud G. Fatty acid proportions in cholesterol esters and risk of premature death from cancer in middle aged French men. BMJ 1995;311:1251-4.
11. Kilander L, Berglund L, Boberg M, Vessby B, Lithell H. Education, lifestyle factors and mortality from cardiovascular disease and cancer. A 25-year follow-up of Swedish 50-year-old men. Int J Epidemiol 2001;30:1119-26. (Pubitemid 33049050)
12. Hodson L, Fielding BA. Stearoyl-CoA desaturase: rogue or innocent bystander? Prog Lipid Res 2013;52:15-42.
13. Vessby B, Gustafsson I-B, Tengblad S, Berglund L. Indices of fatty acid desaturase activity in healthy human subjects: effects of different types of dietary fat. Br J Nutr 2013;110:871-9.
14. Holder AM, Gonzalez-Angulo AM, Chen H, Akcakanat A, Do KA, Fraser Symmans W, Pusztai L, Hortobagyi GN, Mills GB, Meric-Bernstam F. High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients. Breast Cancer Res Treat 2013;137:319-27.
15. Igal RA. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 2010;31:1509-15.
16. Roongta UV, Pabalan JG, Wang X, Ryseck RP, Fargnoli J, Henley BJ, Yang WP, Zhu J, Madireddi MT, Lawrence RM, et al. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer Res 2011;9:1551-61.
17. Bougnoux P, Chajès V, Lanson M, Hacene K, Body G, Couet C, Le Floch O. Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma. Breast Cancer Res Treat 1992;20:185-94.
18. Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avancès C, Allory Y, de la Taille A, Culine S, Blancou H, et al. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther 2010;9:1740-54.
19. Scaglia N, Caviglia JM, Igal RA. High stearoyl-CoA desaturase protein and activity levels in simian virus 40 transformed-human lung fibroblasts. Biochim Biophys Acta 2005;1687:141-51.
20. Scaglia N, Igal RA. Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells. J Biol Chem 2005;280:25339-49. (Pubitemid 40962236)
21. Uppsala Longitudinal Study of Adult Men (ULSAM). Version current 1 April 2013. Available from: http://www.pubcare.uu.se/ULSAM/(cited 23 April 2013).
22. Byberg L, Melhus H, Gedeborg R, Sundström J, Ahlbom A, Zethelius B, Berglund LG, Wolk A, Michaëlsson K. Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ 2009;338:b688.
23. Sjögren P, Becker W, Warensjö E, Olsson E, Byberg L, Gustafsson IB, Karlström B, Cederholm T. Mediterranean and carbohydrate-restricted diets and mortality among elderly men: a cohort study in Sweden. Am J Clin Nutr 2010;92:967-74.
24. Fair A, Montgomery K. Energy balance, physical activity, and cancer risk. In: Verma M, ed. Cancer epidemiology. Methods in molecular biology. New York, NY: Humana Press, 2009:57-88.
25. Nydahl M, Gustafsson IB, Mohsen R, Becker W. Comparison between optical readable and open-ended weighed food records. Food Nutr Res 2009;53.
26. Becker W. Befolkningens kostvanor och näringsintag i Sverige 1989. Swedish. [Food habits and intake in Sweden 1989.] Uppsala, Sweden: The Swedish National Food Administration, 1994 (in Swedish).
27. Öhrvall M, Berglund L, Salminen I, Lithell H, Aro A, Vessby B. The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up. Atherosclerosis 1996;127:65-71. (Pubitemid 26425843)
28. Warensjö E, Ingelsson E, Lundmark P, Lannfelt L, Syvänen AC, Vessby B, Riserus U. Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity. Obesity (Silver Spring) 2007;15:1732-40. (Pubitemid 47264952)
29. Cornelis MC, Qi L, Zhang C, Kraft P, Manson J, Cai T, Hunter DJ, Hu FB. Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry. Ann Intern Med 2009;150:541-50.
30. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
31. Collins JM, Neville MJ, Hoppa MB, Frayn KN. De novo lipogenesis and stearoyl-CoA desaturase are coordinately regulated in the human adipocyte and protect against palmitate-induced cell injury. J Biol Chem 2010;285:6044-52.
32. Peter A, Weigert C, Staiger H, Machicao F, Schick F, Machann J, Stefan N, Thamer C, Haring HU, Schleicher E. Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 2009;58:1757-65.
33. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008;27:1133-63. (Pubitemid 351395448)
34. Nakamura MT, Nara TY. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr 2004;24:345-76.
35. Ntambi JM, Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism. Prog Lipid Res 2004;43:91-104. (Pubitemid 37487985)
36. Hess D, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS ONE 2010;5:e11394.
37. Minville-Walz M, Pierre AS, Pichon L, Bellenger S, Fevre C, Bellenger J, Tessier C, Narce M, Rialland M. Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells. PLoS ONE 2010;5:e14363.
38. Kositsawat J, Flanigan RC, Meydani M, Choi YK, Freeman VL. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer. J Urol 2007; 178:2391-6. (Pubitemid 350052153)